Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel
| Image |  |
|---|---|
| Description | scientific article published on 24 June 2011 |
| Author/s |
author: Alan R. Shuldiner |
| Publication date | June 24, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |